Evidence map›Paper›PMID 31119867›Full record

ArticleAutism research : official journal of the International Society for Autism Research2019

Gastrointestinal dysfunction in patients and mice expressing the autism-associated R451C mutation in neuroligin-3.

Suzanne Hosie, Melina Ellis, Mathusi Swaminathan, Fatima Ramalhosa, Gracia O Seger, Gayathri K Balasuriya, Christopher Gillberg, Maria Råstam, Leonid Churilov, Sonja J McKeown and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Autism research : official journal of the International Society for Autism Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Comparing the Gut Microbiome in Autism and Preclinical Models: A Systematic Review.Frontiers in cellular and infection microbiology · 2022
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Frontiers in neuroscience · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 5 countries.

Suzanne HosieSchool of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.ORCID 0000-0001-8569-2912
Melina EllisDepartment of Physiology, The University of Melbourne, Parkville, VIC, Australia.
Mathusi SwaminathanDepartment of Physiology, The University of Melbourne, Parkville, VIC, Australia.
Fatima RamalhosaLife and Health Sciences Research Institute, University of Minho, Braga, Portugal.
Gracia O SegerDepartment of Physiology, The University of Melbourne, Parkville, VIC, Australia.
Gayathri K BalasuriyaSchool of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.ORCID 0000-0003-3411-4543
Christopher GillbergGillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, University of Gothenburg, Göteborg, Sweden.ORCID 0000-0001-8848-1934
Maria RåstamGillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, University of Gothenburg, Göteborg, Sweden.ORCID 0000-0003-0819-3946
Leonid ChurilovSchool of Science Cluster, RMIT University, Melbourne City Campus, Melbourne, VIC, Australia.
Sonja J McKeownCancer Program, Monash Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.ORCID 0000-0002-7318-116X
Nalzi YalcinkayaTexas Children's Microbiome Center, Texas Children's Hospital and Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Petri UrvilTexas Children's Microbiome Center, Texas Children's Hospital and Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Tor SavidgeTexas Children's Microbiome Center, Texas Children's Hospital and Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Carolyn A BellLa Trobe University, Department of Physiology, Anatomy & Microbiology, School of Life Sciences, Bundoora, VIC, Australia.
Oonagh BodinLa Trobe University, Department of Physiology, Anatomy & Microbiology, School of Life Sciences, Bundoora, VIC, Australia.
Jen WoodLa Trobe University, Department of Physiology, Anatomy & Microbiology, School of Life Sciences, Bundoora, VIC, Australia.
Ashley E FranksLa Trobe University, Department of Physiology, Anatomy & Microbiology, School of Life Sciences, Bundoora, VIC, Australia.ORCID 0000-0003-1664-6060
Joel C BornsteinDepartment of Physiology, The University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0002-7518-7717
Elisa L Hill-YardinSchool of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
The University of Melbourne · AULa Trobe University · AUBaylor College of Medicine · USRMIT University · AUDiscovery Institute · USFlorey Institute of Neuroscience and Mental Health · AULund University · SEUniversity of Gothenburg · SEUniversity of Minho · PT

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Decoding Antibiotic-induced Susceptibility to Clostridium difficile InfectionU01AI124290 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A, GAREY, KEVIN W · 2016 to 2020
$7.9M
Allosteric therapy of the Clostridium difficile toxinsR01AI100914 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SAVIDGE, TOR C. · 2012 to 2016
$1.9M
Australian Research Council Future Fellowship FT160100126Congressionally Directed Medical Research Programs AR110134National Health and Medical Research Council APP1047674National Health and Medical Research Council APP566642NIAID NIH HHS R01 AI100914NIAID NIH HHS U01 AI124290NIDDK NIH HHS P30 DK056338RMIT Vice Chancellor's Senior Research FellowshipRoyal Melbourne Hospital Neuroscience Foundation
6 · The paper itself

Abstract

Gastrointestinal (GI) problems constitute an important comorbidity in many patients with autism. Multiple mutations in the neuroligin family of synaptic adhesion molecules are implicated in autism, however whether they are expressed and impact GI function via changes in the enteric nervous system is unknown. We report the GI symptoms of two brothers with autism and an R451C mutation in Nlgn3 encoding the synaptic adhesion protein, neuroligin-3. We confirm the presence of an array of synaptic genes in the murine GI tract and investigate the impact of impaired synaptic protein expression in mice carrying the human neuroligin-3 R451C missense mutation (NL3

Indexed as

DNA Mutational AnalysisAnimalsAutistic DisorderCell Adhesion Molecules, NeuronalComorbidityGastrointestinal DiseasesGastrointestinal MicrobiomeGastrointestinal TransitGene ExpressionHumansMaleMembrane ProteinsMiceMyenteric PlexusNerve Tissue ProteinsNeuronsCell Adhesion Molecules, NeuronalMembrane ProteinsNerve Tissue Proteinsneuroligin 3autismgastrointestinal symptomsgut motilityimmunofluorescencemouseneuroligin-3

Identifiers

PMID31119867
PMCPMC6606367
OpenAlexW2946613508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.